SOX4 and neoplasm: In vivo imaging assays of mice on days 14 and 28 displayed that temozolomide treatment alone or simultaneous treatment of temozolomide and si‐LINC00470 substantially reduced tumor size in mice, while LV‐LINC00470 or LV‐SOX4 transfection markedly abolished the effect of temozolomide treatment in mice (Figure 4G).